Quantitative evaluation of treatment related changes on multi-parametric MRI after laser interstitial thermal therapy of prostate cancer

Laser interstitial thermal therapy (LITT) has recently shown great promise as a treatment strategy for localized, focal, low-grade, organ-confined prostate cancer (CaP). Additionally, LITT is compatible with multi-parametric magnetic resonance imaging (MP-MRI) which in turn enables (1) high resolution, accurate localization of ablation zones on in vivo MP-MRI prior to LITT, and (2) real-time monitoring of temperature changes in vivo via MR thermometry during LITT. In spite of rapidly increasing interest in the use of LITT for treating low grade, focal CaP, very little is known about treatment-related changes following LITT. There is thus a clear need for studying post-LITT changes via MP-MRI and consequently to attempt to (1) quantitatively identify MP-MRI markers predictive of favorable treatment response and longer term patient outcome, and (2) identify which MP-MRI markers are most sensitive to post-LITT changes in the prostate. In this work, we present the first attempt at examining focal treatment-related changes on a per-voxel basis (high resolution) via quantitative evaluation of MR parameters pre- and post-LITT. A retrospective cohort of MP-MRI data comprising both pre- and post- LITT T2-weighted (T2w) and diffusion-weighted (DWI) acquisitions was considered, where DWI MRI yielded an Apparent Diffusion Co-efficient (ADC) map. A spatially constrained affine registration scheme was implemented to first bring T2w and ADC images into alignment within each of the pre- and post-LITT acquisitions, following which the pre- and post-LITT acquisitions were aligned. Pre- and post-LITT MR parameters (T2w intensity, ADC value) were then standardized to a uniform scale (to correct for intensity drift) and then quantified via the raw intensity values as well as via texture features derived from T2w MRI. In order to quantify imaging changes as a result of LITT, absolute differences were calculated between the normalized pre- and post-LITT MRI parameters. Quantitatively combining the ADC and T2w MRI parameters enabled construction of an integrated MP-MRI difference map that was highly indicative of changes specific to the LITT ablation zone. Preliminary quantitative comparison of the changes in different MR parameters indicated that T2w texture may be highly sensitive as well as specific in identifying changes within the ablation zone pre- and post-LITT. Visual evaluation of the differences in T2w texture features pre- and post-LITT also appeared to provide an indication of LITT-related effects such as edema. Our preliminary results thus indicate great potential for non-invasive MP-MRI imaging markers for determining focal treatment related changes, and hence long- and short-term patient outcome.

[1]  Stephen G Bown,et al.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.

[2]  R. Lenkinski,et al.  Elastic registration of multimodal prostate MRI and histology via multiattribute combined mutual information. , 2011, Medical physics.

[3]  Anant Madabhushi,et al.  Weighted Combination of Multi-Parametric MR Imaging Markers for Evaluating Radiation Therapy Related Changes in the Prostate , 2011, Prostate Cancer Imaging.

[4]  R. Lenkinski,et al.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 tesla endorectal, in vivo T2‐weighted MR imagery , 2012, Journal of magnetic resonance imaging : JMRI.

[5]  Anant Madabhushi,et al.  Empirical evaluation of bias field correction algorithms for computer-aided detection of prostate cancer on T2w MRI , 2011, Medical Imaging.

[6]  M. Zelefsky Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer , 2005 .

[7]  Chin-Seng Chua,et al.  Face recognition from 2D and 3D images using 3D Gabor filters , 2005, Image Vis. Comput..

[8]  Oliver Sartor,et al.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.

[9]  A. Villers,et al.  Prostate cancer characterization on MR images using fractal features. , 2010, Medical physics.

[10]  W. R. Lees,et al.  Dynamic magnetic resonance control of interstitial laser photocoagulation therapy of colorectal hepatic metastases , 1994, The Lancet.

[11]  I. Hsu,et al.  T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. , 2009, International braz j urol : official journal of the Brazilian Society of Urology.

[12]  A Fenster,et al.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial. , 2009, The Journal of urology.

[13]  Jayaram K. Udupa,et al.  New methods of MR image intensity standardization via generalized scale , 2005, SPIE Medical Imaging.

[14]  Hashim Uddin Ahmed,et al.  The index lesion and the origin of prostate cancer. , 2009, The New England journal of medicine.

[15]  D. Pucar,et al.  The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery , 2008, Current opinion in urology.

[16]  Toyoaki Uchida,et al.  Treatment of localized prostate cancer using high‐intensity focused ultrasound , 2006, BJU international.

[17]  Dimitris N. Metaxas,et al.  Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI , 2005, IEEE Transactions on Medical Imaging.

[18]  J. Kurhanewicz,et al.  Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.

[19]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[20]  Anant Madabhushi,et al.  Textural Kinetics: A Novel Dynamic Contrast-Enhanced (DCE)-MRI Feature for Breast Lesion Classification , 2011, Journal of Digital Imaging.

[21]  Peter Gibbs,et al.  Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. , 2006, Magnetic resonance imaging.

[22]  C. Kim,et al.  Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. , 2010, AJR. American journal of roentgenology.

[23]  Jayaram K. Udupa,et al.  New variants of a method of MRI scale standardization , 2000, IEEE Transactions on Medical Imaging.

[24]  T. H. van der Kwast,et al.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.

[25]  Andrew B Rosenkrantz,et al.  Role of MRI in minimally invasive focal ablative therapy for prostate cancer. , 2011, AJR. American journal of roentgenology.

[26]  Anant Madabhushi,et al.  CADOnc ⓒ: An integrated toolkit for evaluating radiation therapy related changes in the prostate using multiparametric MRI , 2011, 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[27]  T. Stamey,et al.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.

[28]  R Jason Stafford,et al.  Laser-induced thermal therapy for tumor ablation. , 2010, Critical reviews in biomedical engineering.

[29]  A. Ouzzane,et al.  Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future , 2012, Advances in urology.